SAFETY, TOLERABILITY, PHARMACOKINETICS AND ANTIVIRAL ACTIVITY FOLLOWING SINGLE- AND MULTIPLE-DOSE ADMINISTRATION OF BMS-650032, A NOVEL HCV NS3 INHIBITOR, IN SUBJECTS WITH CHRONIC GENOTYPE 1 HCV INFECTIONClaudio Pasquinelli,Timothy Eley, Criseldo Villegas,Katrina Sandy, Elton Mathias,Pamela Wendelburg,Shanmei Liao,Fiona McPhee,Paul M. Scola,Li-Qiang Sun,Thomas C. Marbury,Eric Lawitz,R. Goldwater,Maribel Rodriguez-Torres,Michael P. DeMicco, Michelle Ababa,David Wright,Michael Charlton,Walter K. Kraft,Juan Carlos Lopez-Talavera,Dennis M. GraselaHEPATOLOGY（2009）引用 1|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
